Medicare Enrolled

Dr. Robert Sisk, MD

Ophthalmology · Cincinnati, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1945 CEI DR, Cincinnati, OH 45242
5135693741
In practice since 2007 (19 years)
NPI: 1063614089 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sisk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sisk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sisk

Dr. Robert Sisk is an ophthalmology specialist in Cincinnati, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sisk performed 40,254 Medicare services across 2,002 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sisk received a total of $46,612 from 28 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sisk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in OH $46,612 industry payments

Medicare Practice Summary

Medicare Utilization ↗
40,254
Medicare services
Top 1% in OH for ophthalmology
2,002
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,119 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
32,100 $29 $40
Verteporfin injection, 0.1 mg
An injection of verteporfin medication with a dosage of 0.1 mg.
1,790 $9 $45
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,607 $28 $158
Aflibercept eye injection (Eylea) 1,414 $692 $3,783
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,284 $93 $508
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
667 $349 $557
Injection, brolucizumab-dbll, 1 mg 432 $248 $1,270
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
388 $85 $506
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
329 $58 $356
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
104 $80 $487
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
49 $99 $445
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
24 $93 $658
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
16 $382 $2,015
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $74 $439
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
12 $870 $4,502
Retinal vascular growth destruction by photodynamic therapy
This procedure uses photodynamic therapy to destroy abnormal vascular growth located between the retina and the sclera.
12 $209 $1,095
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
12 $113 $580
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$46,612
Total received (2018-2024)
Avg $6,659/year across 7 years
Top 5% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$38,719 (83.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,727 (12.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,166 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,748
2023
$2,675
2022
$5,225
2021
$10,174
2020
$10,620
2019
$287
2018
$1,883

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EyePoint Pharmaceuticals US, Inc.
$10,175
Astellas Pharma US Inc
$2,701
Apellis Pharmaceuticals, Inc.
$1,993
Regeneron Healthcare Solutions, Inc.
$292
Genentech USA, Inc.
$184
Astellas US LLC
$136
Alimera Sciences, Inc.
$118
ABBVIE INC.
$76
Bausch & Lomb Americas Inc.
$55
Oyster Point Pharma, Inc.
$17
Top 3 companies account for 94.4% of 2024 payments
All-time payments by company (2018-2024) ›
EyePoint Pharmaceuticals US, Inc.
$18,706
LEICA MICROSYSTEMS INC.
$15,350
Astellas Pharma US Inc
$3,023
Apellis Pharmaceuticals, Inc.
$2,299
Allergan, Inc.
$2,122
Allergan Inc.
$1,333
Genentech USA, Inc.
$1,038
Regeneron Healthcare Solutions, Inc.
$874
Alimera Sciences, Inc.
$511
Alcon Vision LLC
$247
Novartis Pharmaceuticals Corporation
$213
Spark Therapeutics, Inc.
$138
Astellas US LLC
$136
Carl Zeiss Meditec USA, Inc.
$135
Bausch & Lomb Americas Inc.
$93
ABBVIE INC.
$76
Notal Vision, Inc.
$47
AbbVie Inc.
$36
Biogen, Inc.
$36
BioTissue Holdings, Inc.
$29
BIOTISSUE HOLDINGS, INC.
$28
Mallinckrodt LLC
$27
Bausch & Lomb, a division of Bausch Health US, LLC
$27
Marco Ophthalmic, Inc.
$24
Shire North American Group Inc
$17
Horizon Therapeutics plc
$17
Oyster Point Pharma, Inc.
$17
Ellex, Inc
$12
Top 3 companies account for 79.5% of all-time payments
Associated products mentioned in payments ›
2RT Retinal Rejuvination Therapy Laser System · ACTHAR · ARTEVO 800 · BEOVU · DEXYCU · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · ILUVIEN · Iluvien · Izervay · LOTEMAX GEL · LOTEMAX SM · LUXTURNA · Lucentis · NGENUITY · OPD-III · OZURDEX · PROKERA · Proveo 8 · SIMBRINZA · SURGICAL MICROSCOPES · SUSVIMO · Surgical Microscopes · Susvimo · Syfovre · TEPEZZA · TYRVAYA · VABYSMO · VYZULTA · Vabysmo · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for ophthalmology in OH.

Looking for an ophthalmology specialist in Cincinnati?
Compare ophthalmologists in the Cincinnati area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
151
Per 100K population
18.2
County median income
$70,816
Nearest hospital
BETHESDA NORTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sisk is a mixed practice specialist, with above-average Medicare volume (top 1% in OH), with consulting-driven industry engagement in the top 5% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sisk experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Sisk performed 32,100 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sisk receive payments from pharmaceutical companies?
Yes. Dr. Sisk received a total of $46,612 from 28 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sisk's costs compare to other ophthalmologists in Cincinnati?
Dr. Sisk's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sisk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →